next generation glp-1 There's a new name in the GLP conversation — and it's worth paying attention to. Retatrutide is a triple-agonist therapy that targets GLP-1, GIP, and glucagon receptors simultaneously. In clinical trials, it What is the pipeline for

Plus, experts recommend skipping the magic bullet and hiring a personal trainer instead

These FAHFAs can be stored as TAGs (156) and mobilized during cold exposure by PNPLA2 to promote de-novo lipogenesis and FA-esterification in an insulin-independent manner (157), possibly explaining the coupling of lipolysis to lipogenesis in adipocytes (151)

They skirt rules by claiming their peptides are "not for human use," but for "research purposes only." Since black market Chinese products dominate the market, how does the FDA's ban actually "protect" us

GSH works to modulate the behavior of many immune cells, augmenting both, innate immunity (and trained innate immunity or innate immune memory

grants 2R01HL098032, 1R01HL125886-01, P01HL103455, T32 HL110849 and T32 HL007563), the Institute for Transfusion Medicine and the Hemophilia Center of Western Pennsylvania

Rather than directly supplying NAD+ precursors (like NMN or NR), it works by blocking an enzyme that consumes nicotinamide, theoretically preserving the substrate pool for endogenous NAD+ production